Agrow is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Sian Lazell

Sian joined the Animal Pharm team in February 2015 after graduating with a degree in English Literature with Psychology from Bath Spa University.

Sian writes about emerging start-up companies and new research from academia. She is especially interested in the pet health space, as well as the introduction of digital technology for both companion animals and livestock. She also has an interest in increasing Animal Pharm's equine coverage, as she owns horses herself.

In addition to covering animal health news and conducting interviews with worldwide companies, Sian also works on the evolving Animal Pharm Product Approvals Index.
Set Alert for Articles By Sian Lazell

Latest From Sian Lazell

Genus finance director appointed new chief executive

UK animal genetics firm Genus has appointed Stephen Wilson chief executive.


Europe witnesses more approvals in H1 than whole of 2018

Europe has witnessed more centralized approvals for new animal health products in the first six months of 2019 than the entire number for last year.

Europe Product Approvals

FAO calls on African governments to regulate urban livestock space

The FAO has warned a growing farming sector around African cities poses a public health threat if not properly regulated.

FAO Food Animals

Stonehaven strengthens team with ex-Elanco marketing specialist

Stonehaven Consulting has selected Arthur Redpath as its senior global marketing expert.


AGL maximizes animal health tech potential with IBM IoT partnership

US animal analytics and technology services specialist AGL Technology is working with IBM Watson Internet of Things (IoT) to expand its capabilities.

Equipment & Technology Deals

Sanfer bags $500m investment for continued expansion, further acquisitions

Mexican pharmaceutical firm Sanfer has received a $500 million from long-term investor Caisse de dépôt et placement du Québec (CDPQ).

Investments Pharmaceuticals
See All